How severe is CVE-2022-22497?

CVE-2022-22497 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2022-22497 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (65th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-22497?

CVE-2022-22497 primarily affects Ibm Aspera Faspex. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2022-22497?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-22497 published?

CVE-2022-22497 was published on 2022-05-24 and last updated on 2026-06-17.

CVE-2022-22497

CVE-2022-22497 is a high-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: High (CVSS 3.x base score 7.5)
CVSS v2: 5.0
EPSS exploit prediction: 1% (65th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Ibm Aspera Faspex
Published: 2022-05-24
Last modified: 2026-06-17

Description

IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. IBM X-Force ID: 226951.

Frequently asked questions

What is CVE-2022-22497?: IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. IBM X-Force ID: 226951.
How severe is CVE-2022-22497?: CVE-2022-22497 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2022-22497 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (65th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-22497?: CVE-2022-22497 primarily affects Ibm Aspera Faspex. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2022-22497?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-22497 published?: CVE-2022-22497 was published on 2022-05-24 and last updated on 2026-06-17.

References

Affected products (2)

cpe:2.3:a:ibm:aspera_faspex:4.4.1:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:5.0.0:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2026-14959 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
CVE-2026-14958 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
CVE-2026-14996 — High (CVSS 8.2): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…

All CVEs affecting Ibm Aspera Faspex →